Spectral Medical Inc T.EDT

Today's Call

[TechOne]

I did not listen to it so what I have summarized from posts here so please tell me know I got it.. Or not.. 

1.  Baxter made the extension deal and paid the 2nd milestone, CAD $ 2M without looking at the intrim data.

2.  Baxter will wait till they get the numbers when the trial is completed. Does not want data leak or any issue with FDA regarding the trial..

3.  Spectral still needs $17-18 M to take the trial to conclusion etc. etc. 

So hence, no firework in POS and we are still on the same trajectory of slow burn for next few months until it is all done.. 

Does that cover it or did I miss something..  Thanks..

[palinc2000]

They said they were pleased with the results so far (or something like that) and they will no longer make comments such as @exceeding expectations!! Which also means I think that they will not disclose in future PR s  if NOT meeting expectations    

[Spamme54321]

You got the major points. Some additional color. - They must read this message board because they addressed Kellum not being quoted on the recent news releases. Basiclly he is busy working on the trial - Some of the 12 million Warrants at 0.5 have been excercised. I think .5 will be the next battleground for the POS. Because no way you can buy 12 million shares of Spectral without driving the